* Illumina Inc ILMN.OQ reported quarterly adjusted
earnings of 9
cents per share for the quarter ended in March, higher than
the same quarter last year, when the company reported EPS of 8
cents. The mean expectation of nineteen analysts for the
quarter was for earnings of 4 cents per share. Wall Street
expected results to range from -11 cents to 25 cents per share.
* Revenue fell 1% to $1.08 billion from a year ago; analysts
expected $1.05 billion.
* Illumina Inc's reported EPS for the quarter was a loss
of 79
cents.
* The company reported a quarterly loss of $126 million.
* Illumina Inc shares had fallen by 9.7% this quarter and
lost 11.0% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 36.7%
in the last three months.
* In the last 30 days, three analysts negatively revised
earnings
estimates
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 9 "strong buy" or "buy," 12
"hold" and 3 "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "hold"
Wall Street's median 12-month price target for Illumina Inc is
$145.00
This summary was machine generated from LSEG data May 3 at 01:36
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.04 0.09 Beat
Dec. 31 2023 0.02 0.14 Beat
Sep. 30 2023 0.12 0.33 Beat
Jun. 30 2023 0.02 0.32 Beat